Patient Square Capital »

Beigene shares owned by Patient Square Capital

Quarter-by-quarter ownership of Beigene (ONC) shares owned by Patient Square Capital from 13F filings

Historical chart of Patient Square Capital investment in Beigene

Tip: Access up to 7 years of quarterly data

All positions including Beigene held by Patient Square Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beigene by Patient Square Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $21M 69k 303.81

More positions owned by Patient Square Capital

Roivant Sciences SHS (ROIV)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Argenx Se Sponsored Adr (ARGX)
Beone Medicines Sponsored Ads (ONC)
Abivax Sa Sponsored Ads (ABVX)
Pharvaris N V (PHVS)
Eyepoint Com New (EYPT)
Terns Pharmaceuticals (TERN)
Celcuity (CELC)
Cogent Biosciences (COGT)
Kymera Therapeutics (KYMR)
Liquidia Corporation Com New (LQDA)
Dbv Technologies S A Sponsored Ads (DBVT)
Allogene Therapeutics (ALLO)

View all positions for Patient Square Capital

Top funds holding Beigene

Baker Bros. Advisors
Capital Research and Management Company - Division 3
PRIMECAP Management Company
FMR
Hillhouse Capital Advisors
Temasek Holdings
BlackRock
Siren
Capital International
Baird Financial
Man Group
Candriam Luxembourg S.C.A.
Nuveen
Bnp Paribas Arbitrage, Snc
Artisan Partners Limited Partnership

View all funds holding Beigene